Indiaโs first intranasal anti-Covid vaccine, manufactured by Hyderabad-based Bharat Biocon, has been approved by the Drugs Controller General of India (DGCI). The vaccine can be used forโฆ
View More Bharat Biotech Anti-Covid Nasal Vaccine Approvedintranasal vaccine
Bharat Biotech Completes Phase III Trial Of Intranasal Covid Vaccine
Bharat Biotech International Limited (BBIL) on Monday said that it has completed the phase III trials and booster doses for the Covaxin Intranasal Covid-19 vaccine.
View More Bharat Biotech Completes Phase III Trial Of Intranasal Covid Vaccine